251 related articles for article (PubMed ID: 19896824)
1. Discovery and development of biopharmaceuticals: current issues.
Strohl WR; Knight DM
Curr Opin Biotechnol; 2009 Dec; 20(6):668-72. PubMed ID: 19896824
[No Abstract] [Full Text] [Related]
2. Pharmacological significance of glycosylation in therapeutic proteins.
Li H; d'Anjou M
Curr Opin Biotechnol; 2009 Dec; 20(6):678-84. PubMed ID: 19892545
[TBL] [Abstract][Full Text] [Related]
3. HTS technologies in biopharmaceutical discovery.
Wu G; Doberstein SK
Drug Discov Today; 2006 Aug; 11(15-16):718-24. PubMed ID: 16846799
[TBL] [Abstract][Full Text] [Related]
4. Drug Discovery Technology and Development 2005 - IBC's Tenth World Congress. Emerging and early stage company showcase pre-conference symposium.
Razvi ES
IDrugs; 2005 Oct; 8(10):796-8. PubMed ID: 16254794
[No Abstract] [Full Text] [Related]
5. [Microbial biopharmaceuticals and antibody-based drugs--promising for new drug discovery and development].
Zhen YS
Yao Xue Xue Bao; 2003 Jul; 38(7):483-4. PubMed ID: 14515788
[No Abstract] [Full Text] [Related]
6. Biopharmaceuticals in China.
Hu X; Ma Q; Zhang S
Biotechnol J; 2006 Nov; 1(11):1215-24. PubMed ID: 17089435
[TBL] [Abstract][Full Text] [Related]
7. Second-Generation Pharmaceutical Proteins-EUFEPS Workshop on Optimizing Biotech Medicines.
Pasut G; Veronese FM
IDrugs; 2007 Mar; 10(3):162-4. PubMed ID: 17351866
[No Abstract] [Full Text] [Related]
8. Strategies to improve oral drug bioavailability.
Gomez-Orellana I
Expert Opin Drug Deliv; 2005 May; 2(3):419-33. PubMed ID: 16296764
[TBL] [Abstract][Full Text] [Related]
9. Flexibility--the guiding principle for antibody manufacturing.
Carson KL
Nat Biotechnol; 2005 Sep; 23(9):1054-8. PubMed ID: 16151390
[TBL] [Abstract][Full Text] [Related]
10. Applying technologies towards safe and effective medicines.
Roses AD
Biotechniques; 2005 Oct; 39(4):563-4. PubMed ID: 16235568
[No Abstract] [Full Text] [Related]
11. Society for Biomolecular Sciences--15th Annual Conference. Bioassay and technology innovation: 15 years of shaping drug discovery. 26-30 April 2009, Lille, France.
Napper AD
IDrugs; 2009 Jun; 12(6):363-5. PubMed ID: 19517316
[No Abstract] [Full Text] [Related]
12. Biopharmaceutical drug discovery using novel protein scaffolds.
Gill DS; Damle NK
Curr Opin Biotechnol; 2006 Dec; 17(6):653-8. PubMed ID: 17055245
[TBL] [Abstract][Full Text] [Related]
13. Plant-based production of biopharmaceuticals.
Fischer R; Stoger E; Schillberg S; Christou P; Twyman RM
Curr Opin Plant Biol; 2004 Apr; 7(2):152-8. PubMed ID: 15003215
[TBL] [Abstract][Full Text] [Related]
14. Formulation and manufacturability of biologics.
Shire SJ
Curr Opin Biotechnol; 2009 Dec; 20(6):708-14. PubMed ID: 19880308
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive survey of chemical libraries for drug discovery and chemical biology: 2006.
Dolle RE; Le Bourdonnec B; Goodman AJ; Morales GA; Salvino JM; Zhang W
J Comb Chem; 2007; 9(6):855-902. PubMed ID: 17877417
[No Abstract] [Full Text] [Related]
16. Bioreactor technology: a novel industrial tool for high-tech production of bioactive molecules and biopharmaceuticals from plant roots.
Sivakumar G
Biotechnol J; 2006 Dec; 1(12):1419-27. PubMed ID: 17136730
[TBL] [Abstract][Full Text] [Related]
17. Synthetic library design.
Huwe CM
Drug Discov Today; 2006 Aug; 11(15-16):763-7. PubMed ID: 16846805
[TBL] [Abstract][Full Text] [Related]
18. Drug discovery beyond the 'rule-of-five'.
Zhang MQ; Wilkinson B
Curr Opin Biotechnol; 2007 Dec; 18(6):478-88. PubMed ID: 18035532
[TBL] [Abstract][Full Text] [Related]
19. Novel fluorescent proteins for high-content screening.
Wolff M; Wiedenmann J; Nienhaus GU; Valler M; Heilker R
Drug Discov Today; 2006 Dec; 11(23-24):1054-60. PubMed ID: 17129823
[TBL] [Abstract][Full Text] [Related]
20. Informatics and modeling challenges in fragment-based drug discovery.
Hubbard RE; Chen I; Davis B
Curr Opin Drug Discov Devel; 2007 May; 10(3):289-97. PubMed ID: 17554855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
